EVANSTON, Ill., May 3 /PRNewswire-FirstCall/ -- Northfield Laboratories Inc. announced today that Steven A. Gould, M.D., Chairman and Chief Executive Officer, will be presenting at the Rodman & Renshaw Techvest Global Healthcare Conference on Wednesday, May 12, 2004 at 7:20 a.m. ET (12:20 p.m. in London), at Claridge's Hotel, London, UK.
Interested investors can access the live audio webcast of the presentation at http://www.northfieldlabs.com/. A replay of the presentation will be available and will be archived for two weeks.
About Northfield Laboratories
Northfield Laboratories Inc. is the leader in developing an oxygen- carrying blood substitute, PolyHeme(R), for the treatment of urgent, large volume blood loss in trauma and resultant surgical settings. Enrollment is underway in a pivotal Phase III trial of PolyHeme in the pre-hospital setting. PolyHeme(R) is a solution of chemically modified human hemoglobin that requires no cross matching and is therefore compatible with all blood types. It has a shelf life of over 12 months.
For further information on Northfield Laboratories, visit the website at http://www.northfieldlabs.com/
Sophia H. Twaddell Sharon L. Weinstein
Vice President, Corporate Communications Noonan Russo Presence
(847) 864-3500 (212) 845-4271
Northfield Laboratories Inc.
CONTACT: Sophia H. Twaddell, Vice President, Corporate Communications ofNorthfield Laboratories Inc., +1-847-864-3500, email@example.com;or Sharon L. Weinstein of Noonan Russo Presence, +1-212-845-4271,firstname.lastname@example.org, for Northfield Laboratories Inc.